US 11427823
Targeted compositions
granted A61KA61K47/549A61K47/554
Quick answer
US patent 11427823 (Targeted compositions) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Grant date
- Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K47/549, A61K47/554, A61P, A61P1/16